Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H 2 S-Amplified Ferroptosis Therapy
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c09066 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Jiezhao Zhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong 510515, China. Hauptthemen laut MEDLINE: Ferroptosis, Hydrogen Sulfide, Gold, Metal Nanoparticles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Guangzhou Municipal Science and Technology Program key projects, National Natural Science Foundation of China.
Abstract (Originalsprache)
Recently, nanozymes with peroxidase (POD)-like activity have shown great promise for ferroptosis-based tumor therapy, which are capable of transforming hydrogen peroxide (H2O2) to highly toxic hydroxyl radicals (•OH). However, the unsatisfactory therapeutic performance of nanozymes due to insufficient endogenous H2O2 and acidity at tumor sites has always been a conundrum. Herein, an ultrasmall gold (Au) @ ferrous sulfide (FeS) cascade nanozyme (AuNP@FeS) with H2S-releasing ability constructed with an Au nanoparticle (AuNP) and an FeS nanoparticle (FeSNP) is designed to increase the H2O2 level and acidity in tumor cells via the collaboration between cascade reactions of AuNP@FeS and the biological effects of released H2S, achieving enhanced •OH generation as well as effective ferroptosis for tumor therapy. The cascade reaction in tumor cells is activated by the glucose oxidase (GOD)-like activity of AuNP in AuNP@FeS to catalyze intratumoral glucose into H2O2 and gluconic acid; meanwhile, the released H2S from AuNP@FeS reduces H2O2 consumption by inhibiting intracellular catalase (CAT) activity and promotes lactic acid accumulation. The two pathways synergistically boost H2O2 and acidity in tumor cells, thus inducing a cascade to generate abundant •OH by catalyzing H2O2 through the POD-like activity of FeS in AuNP@FeS and ultimately causing amplified ferroptosis. In vitro and in vivo experiments demonstrated that AuNP@FeS presents a superior tumor therapeutic effect compared to that of AuNP or FeS alone. This strategy represents a simple but powerful method to amplify ferroptosis with H2S-releasing cascade nanozymes and will pave a new way for the development of tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong 510515, China.
- Department of Biomedical Science, BK21 FOUR Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon 22212, South Korea.
ORCID-Profile: Zheyu Shen
Förderung
- China Postdoctoral Science Foundation
- Guangzhou Municipal Science and Technology Program key projects
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhan, J., Liu, J., Yang, J., Huang, L., Lu, Y., Lu, X., Zhu, J., Yang, S., & Shen, Z. (2023). Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H 2 S-Amplified Ferroptosis Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c09066
Vancouver
Zhan J, Liu J, Yang J, Huang L, Lu Y, Lu X, et al. Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H 2 S-Amplified Ferroptosis Therapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c09066
BibTeX
@article{Zhan2023,
author = {Zhan, Jiezhao and Liu, Jianping and Yang, Jing and Huang, Lin and Lu, Yudie and Lu, Xuanyi and Zhu, Jiaoyang and Yang, Sugeun and Shen, Zheyu},
title = {Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H 2 S-Amplified Ferroptosis Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c09066}
}
EUVIMED